Robuta

Enhancing the management of Gaucher disease patients through multidimensional risk assessment serves as a roadmap towards personalized medicine in the context...

Anti-CGRP therapies for migraine in multiple sclerosis patients

In this project, various questions regarding the efficacy of approved multiple sclerosis (MS) therapies were analyzed. This included descriptive analyses of...

Working with mice, scientists who tested drugs intended to halt growth of brain cancer stem cells -- a small population of cells within tumors that perpetuate...

Join us on March 27 and April 10

Using the largest cohort of people with MS and COVID-19 available, we demonstrated consistent associations of rituximab with increased risk of hospitalization,...